Exclusive

Publication

Byline

Strikes in Ukraine and Russia kill at least 16 on Chernobyl anniversary

New Delhi, April 27 -- Strikes across Ukraine, Russian-occupied territory and Russia over the past day killed at least 16 people, authorities said Sunday as the 40th anniversary of the Chernobyl nucle... Read More


Veteran actor Bharat Kapoor dies at 80 due to cardiac arrest

India, April 27 -- Veteran actor Bharat Kapoor passed away on April 27, in Mumbai at the age of 80. According to multiple reports, he died at around 3:30pm at Sion Hospital after suffering from multip... Read More


Stress Testing: Are the best-performing IPOs of 2025 managing to hold ground amid market meltdown?

New Delhi, April 27 -- While the Indian primary market may have cooled off due to a meltdown on Dalal Street this year, the top-performing debutants of 2025 have largely remained on a firm footing. T... Read More


Fact Check: Is Former Arsenal Star Nicolas Pepe Dating Ex-Porn Star Lana Rhoades After Split With Teanna Trump? Truth Behind Viral Tweet

India, April 27 -- Nicolas Pepe doesn't seem to stay single for long, and if the latest viral tweet is to be believed, the Villarreal winger has once again found himself in the spotlight. Known for hi... Read More


Maha: Court refuses to grant interim protection to accused Nida Khan in Nashik TCS case, reserves order on her plea till May 2

Mumbai, April 27 -- A sessions court in Maharashtra's Nashik district today refused to grant interim protection to Nida Khan, prime accused in the sexual harassment and religious coercion case at Tata... Read More


Singapore Clinical Trial: A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined with Chemotherapy Versus Investigator’s Choice of TKI Combined with Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Singapore, April 27 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combi... Read More


Singapore Clinical Trial: 'Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post-operative survival of glaucoma drainage devices'

Singapore, April 27 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... Read More


Singapore Clinical Trial: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.

Singapore, April 27 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... Read More


Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, April 27 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... Read More


Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, April 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safe... Read More